Short answer
MAXCYTE, INC. (MXCT) filed an 8-K current report with the SEC on October 14, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Preliminary unaudited revenue results for quarter ended September 30, 2026.
MAXCYTE, INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Preliminary unaudited revenue results for quarter ended September 30, 2026
- Full-year 2026 revenue guidance increased, signaling stronger expected business performance
- Results remain subject to quarter-end close and interim financial statement review
- Independent auditor has not reviewed or audited the preliminary figures
- Exhibit 99.1 contains the revenue figures and updated guidance details
Item EX-99.1 · Exhibit EX-99.1
- Preliminary Q3 core revenue $8.1M, up 26% year over year, signaling resumed growth
- SPL program revenue exceeded $1.0M, including a $1.0M milestone payment
- FY2026 revenue guidance raised to approximately $34M from prior $30M-$32M
- FY2026 core revenue guidance increased to approximately $28M, up from $25M-$27M
- SPL guidance raised to approximately $6M, including $4M milestones and $2M royalties
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other MAXCYTE, INC. 8-K filings
Get the next MXCT 8-K as it lands
Follow MXCT for push alerts, or ask the research agent what this filing means.